Table 2 Inclusion and exclusion criteria for the systematic review

Inclusion criteria

Aims:

* Prevalence of well-characterized onconeural antibodies in patients with psychiatric disorders

* Psychiatric symptomatology of onconeural antibody positive patients in patients with psychiatric disorders, malignancies and/or paraneoplastic neurological syndromes

Design: Retrospective, prospective, observational and/or interventional

Exclusion criteria

Study sample < 5 patients

Pediatric or adolescent patients (age < 18)

Non-validated methods for onconeural antibody testing